Regional hyperthermia for soft tissue sarcoma – a survey on current practice, controversies and consensus among 12 European centers

References

• Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;18(11):e630–e570. doi: 10.1016/S1470-2045(10)70071-1.
   Google Scholar
• Angele MK, Albertsmeier M, Prix NJ, et al. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg. 2014;260(5):749–756; discussion 54–56. doi: 10.1097/SLA.0000000000000978.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. JAMA Oncol. 2018;4(4):483–492. doi: 10.1001/jamaoncol.2017.4996.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(11):1348–1365. doi: 10.1016/j.annonc.2021.07.006.
   PubMed Web of Science ®Google Scholar
• Deutsche Krebsgesellschaft DK. AWMF. S3-Leitlinie adulte weichgewebesarkome, langversion version 1.0. 2021. Leitlinienprogramm Onkologie. 2021;1.1:119–121.
   Google Scholar
• Rothermundt C, Andreou D, Blay J-Y, et al. Controversies in the management of patients with soft tissue sarcoma: recommendations of the conference on state of science in sarcoma 2022. Eur J Cancer. 2023;180:158–179. doi: 10.1016/j.ejca.2022.11.008.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Vujaskovic Z, Kondo M, et al. The kadota fund international forum 2004–clinical group consensus. Int J Hyperthermia. 2008;24(2):111–122. doi: 10.1080/02656730801895058.
   PubMed Web of Science ®Google Scholar
• Overgaard J. The heat is (still) on–the past and future of hyperthermic radiation oncology. Radiother Oncol. 2013;109(2):185–187. doi: 10.1016/j.radonc.2013.11.004.
   PubMed Web of Science ®Google Scholar
• Veltsista PD, Oberacker E, Ademaj A, et al. Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review. Int J Hyperthermia. 2023;40(1):2236337.
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol. 2011;187(10):605–610. doi: 10.1007/s00066-011-1145-x.
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, et al. Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol. 2012;188(S2):198–211. doi: 10.1007/s00066-012-0176-2.
   PubMed Web of Science ®Google Scholar
• Lagendijk JJW, Van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia. 1998;14(2):125–133. doi: 10.3109/02656739809018219.
   PubMed Web of Science ®Google Scholar
• Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073–1087. doi: 10.1016/j.ijrobp.2015.12.361.
   PubMed Web of Science ®Google Scholar
• Datta NR, Stutz E, Gomez S, et al. Efficacy and safety evaluation of the various therapeutic options in locally advanced cervix cancer: a systematic review and network meta-analysis of randomized clinical trials. Int J Radiat Oncol Biol Phys. 2019;103(2):411–437. doi: 10.1016/j.ijrobp.2018.09.037.
   PubMed Web of Science ®Google Scholar
• Paulides MM, Dobsicek Trefna H, Curto S, et al. Recent technological advancements in radiofrequency- andmicrowave-mediated hyperthermia for enhancing drug delivery. Adv Drug Deliv Rev. 2020;163-164:3–18. doi: 10.1016/j.addr.2020.03.004.
   PubMed Web of Science ®Google Scholar
• Datta NR, Kok HP, Crezee H, et al. Integrating loco-regional hyperthermia Into the current oncology practice: SWOT and TOWS analyses. Front Oncol. 2020;10:819. doi: 10.3389/fonc.2020.00819.
   PubMed Web of Science ®Google Scholar
• Fiorentini G, Sarti D, Gadaleta CD, et al. A narrative review of regional hyperthermia: updates From 2010 to 2019. Integr Cancer Ther. 2020;19:153473542093264–1534735420932648. doi: 10.1177/1534735420932648.
   Web of Science ®Google Scholar
• Issels RD, Abdel-Rahman S, Wendtner C-M, et al. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. Eur J Cancer. 2001;37(13):1599–1608. doi: 10.1016/S0959-8049(01)00183-6.
   PubMed Web of Science ®Google Scholar
• Wendtner C-M, Abdel-Rahman S, Baumert J, et al. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur J Cancer. 2001;37(13):1609–1616. doi: 10.1016/S0959-8049(01)00191-5.
   PubMed Web of Science ®Google Scholar
• Stutz E, Puric E, Ademaj A, et al. Present practice of radiative deep hyperthermia in combination with radiotherapy in Switzerland. Cancers. 2022;14(5):1175. doi: 10.3390/cancers14051175.
   PubMed Web of Science ®Google Scholar
• Hyper-Thermia. Enhanced anti-tumor efficacy of trabectedin; [cited 2024 Feb 08]. Available from: https://classic.clinicaltrials.gov/show/NCT02359474
   Google Scholar
• Keizer HJ, Crowther D, Nielsen OS, et al. EORTC group phase II study of oral etoposide for pretreated soft tissue sarcoma. Sarcoma. 1997;1(2):99–101. doi: 10.1080/13577149778371.
   PubMedGoogle Scholar
• Zhang W, Gou P, Dupret JM, et al. Etoposide, an anticancer drug involved in therapy-related secondary leukemia: enzymes at play. Transl Oncol. 2021;14(10):101169. doi: 10.1016/j.tranon.2021.101169.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Ferrari S, Quagliuolo V, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18(6):812–822. doi: 10.1016/S1470-2045(17)30334-0.
   PubMed Web of Science ®Google Scholar
• Wiedemann G, Roszinski S, Biersack A, et al. Local hyperthermia enhances cyclophosphamide, ifosfamide andcis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol. 1992;118(2):129–135. doi: 10.1007/BF01187501.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio L, Touati N, Blay J-Y, et al. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the european organization for research and treatment of cancer soft tissue and bone sarcoma group. Cancer. 2020;126(11):2637–2647. doi: 10.1002/cncr.32795.
   PubMed Web of Science ®Google Scholar
• Salvador D, Bastos V, Oliveira H. Combined therapy with dacarbazine and hyperthermia induces cytotoxicity in A375 and MNT-1 melanoma cells. Int J Mol Sci. 2022;23(7):5–9.
   Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23(13):3079–3085. doi: 10.1200/JCO.2005.05.520.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Bentzen SM, Overgaard J, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet. 1995;345(8949):540–543. doi: 10.1016/S0140-6736(95)90463-8.
   PubMed Web of Science ®Google Scholar
• Verduijn GM, de Wee EM, Rijnen Z, et al. Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma – a feasibility study. Int J Hyperthermia. 2018;34(7):994–1001. doi: 10.1080/02656736.2018.1454610.
   PubMed Web of Science ®Google Scholar
• Network NCC. Soft tissue sarcoma (Version 2.2021). 2021 [2024 February 08]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf
   Google Scholar
• Callegaro D, Raut CP, Ajayi T, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) versus off-trial (STREXIT) results. Ann Surg. 2023;278(1):127–134. doi: 10.1097/SLA.0000000000005492.
   PubMed Web of Science ®Google Scholar
• Prosnitz LR, Maguire P, Anderson JM, et al. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. Int J Radiat Oncol Biol Phys. 1999;45(4):941–949. doi: 10.1016/S0360-3016(99)00272-2.
   PubMed Web of Science ®Google Scholar
• Spałek MJ, Borkowska AM, Telejko M, et al. The feasibility study of hypofractionated radiotherapy with regional hyperthermia in soft tissue sarcomas. Cancers. 2021;13(6):1332. doi: 10.3390/cancers13061332.
   PubMed Web of Science ®Google Scholar
• Eckert F, Braun LH, Traub F, et al. Radiotherapy and hyperthermia with curative intent in recurrent high risk soft tissue sarcomas. Int J Hyperthermia. 2018;34(7):980–987. doi: 10.1080/02656736.2017.1369174.
   PubMed Web of Science ®Google Scholar
• Eckert F, Gani C, Kluba T, et al. Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas. Strahlenther Onkol. 2013;189(6):482–485. doi: 10.1007/s00066-013-0312-7.
   PubMed Web of Science ®Google Scholar
• Willner A, Agaimy A, Fechner K, et al. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control. Int J Hyperthermia. 2023;40(1):2248424. doi: 10.1080/02656736.2023.2248424.
   PubMedGoogle Scholar
• Wang D, Harris J, Kraybill WG, et al. Pathologic complete response and clinical outcomes in patients with localized soft tissue sarcoma treated with neoadjuvant chemoradiotherapy or radiotherapy: the NRG/RTOG 9514 and 0630 nonrandomized clinical trials. JAMA Oncol. 2023;9(5):646–655. doi: 10.1001/jamaoncol.2023.0042.
   PubMed Web of Science ®Google Scholar
• Cury FL, Viani GA, Gouveia AG, et al. Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS). Radiother Oncol. 2023;190:109935. doi: 10.1016/j.radonc.2023.109935.
   PubMed Web of Science ®Google Scholar
• Roohani S, Ehret F, Kobus M, et al. Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review. Radiat Oncol. 2022;17(1):159. doi: 10.1186/s13014-022-02072-9.
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Gronchi A, Le Péchoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1366–1377. doi: 10.1016/S1470-2045(20)30446-0.
   PubMed Web of Science ®Google Scholar
• Linthorst M, van Geel AN, Baaijens M, et al. Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiother Oncol. 2013;109(2):188–193. doi: 10.1016/j.radonc.2013.05.010.
   PubMed Web of Science ®Google Scholar
• Oldenborg S, Hannoun-Levi J-M. Re-irradiation combined with hyperthermia. In: Kaidar-Person O, Meattini I, Poortmans P, editors. Breast cancer radiation therapy: a practical guide for technical applications. Cham: Springer International Publishing; 2022. p. 413–419.
   Google Scholar
• Parzen JS, Siddiqui ZA, Jawad MS, et al. Reirradiation with concurrent hyperthermia for recurrent breast cancer is safe and effective. Int J Radiat Oncol Biol Phys. 2019;105(1):E45. doi: 10.1016/j.ijrobp.2019.06.2366.
   Web of Science ®Google Scholar
• Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237(2):218–226. doi: 10.1097/01.SLA.0000048448.56448.70.
   PubMed Web of Science ®Google Scholar
• Indelicato DJ, Meadows K, Gibbs CPJr, et al. Effectiveness and morbidity associated with reirradiation in conservative salvage management of recurrent soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2009;73(1):267–272. doi: 10.1016/j.ijrobp.2008.04.032.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg. 2016;263(5):1002–1009. doi: 10.1097/SLA.0000000000001447.
   PubMed Web of Science ®Google Scholar
• Gerner EW, Schneider MJ. Induced thermal resistance in HeLa cells. Nature. 1975;256(5517):500–502. doi: 10.1038/256500a0.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Nielsen OS. The importance of thermotolerance for the clinical treatment with hyperthermia. Radiother Oncol. 1983;1(2):167–178. doi: 10.1016/S0167-8140(83)80019-X.
   PubMedGoogle Scholar
• Izukura R, Imada H, Hashiguchi N, et al. Cardiac and respiratory effects of deep regional hyperthermia using an 8 MHz radiofrequency-capacitive device on patients with cancer. Int J Hyperthermia. 2017;33(4):428–434. doi: 10.1080/02656736.2017.1283064.
   PubMed Web of Science ®Google Scholar
• Adibzadeh F, Sumser K, Curto S, et al. Systematic review of pre-clinical and clinical devices for magnetic resonance-guided radiofrequency hyperthermia. Int J Hyperthermia. 2020;37(1):15–27. doi: 10.1080/02656736.2019.1705404.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Hyperthermic oncology, 1984: proceedings of the 4th international symposium on hyperthermic oncology, held at Aarhus, Denmark, 2–6 July 1984. Aarhus, Denmark: Taylor & Francis; 1984.
   Google Scholar
• Overgaard K, Overcaard J. Radiation sensitizing effect of heat. Acta Radiol Ther Phys Biol. 1974;13(6):501–511.
   PubMed Web of Science ®Google Scholar
• Overgaard K, Overgaard J. Hyperthermic tumour-cell devitalization in vivo. Acta Radiol Ther Phys Biol. 1977;16(1):1–16.
   PubMed Web of Science ®Google Scholar
• Unsoeld M, Lamprecht U, Traub F, et al. MR thermometry data correlate with pathological response for soft tissue sarcoma of the lower extremity in a single center analysis of prospectively registered patients. Cancers. 2020;12(4):959. doi: 10.3390/cancers12040959.
   PubMed Web of Science ®Google Scholar
• Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys. 1998;41(5):1129–1137. doi: 10.1016/S0360-3016(98)00165-5.
   PubMed Web of Science ®Google Scholar
• Surgery with or without neoadjuvant chemotherapy in high risk retroperitoneal sarcoma; [2024 Feb 08]. Available from: https://classic.clinicaltrials.gov/show/NCT04031677
   Google Scholar